Christophe Blanquart

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Molecular oncology

International journal of nanomedicine

Clinical epigenetics

Current oncology (Toronto, Ont.)

CNRS Délégation Bretagne et Pays de Loire

Institut Pasteur de Lille (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CNRS Délégation Bretagne et Pays de Loire

France

CRCN

CRCINA

France

CRCN

CNRS Délégation Paris B

France

CR2

Institut Cochin – INSERM U567/CNRS 8104

France

CR2 CNRS

Institut Cochin – INSERM U567/CNRS 8104

France

Post-Doc

Education History

Institut Pasteur de Lille

France

PHD :: Lipoproteins and atherosclerosis laboratory

Publications

Tina Briolay, Judith Fresquet, Damien Meyer, Brigitte Kerfelec, Patrick Chames, Eléna Ishow, Christophe Blanquart
Specific Targeting of Mesothelin-Expressing Malignant Cells Using Nanobody-Functionalized Magneto-Fluorescent Nanoassemblies. International journal of nanomedicine 19 (2024)
Tina Briolay, Judith Fresquet, Damien Meyer, Brigitte Kerfelec, Patrick Chames, Eléna Ishow, Christophe Blanquart
Specific Targeting of Mesothelin-Expressing Malignant Cells Using Nanobody-Functionalized Magneto-Fluorescent Nanoassemblies. International journal of nanomedicine 19 (2024)
Sabine Paternot, Eric Raspé, Clément Meiller, Maxime Tarabichi, Jean-Baptiste Assié, Frederick Libert, Myriam Remmelink, Xavier Bisteau, Patrick Pauwels, Yuna Blum, Nolwenn Le Stang, Séverine Tabone-Eglinger, Françoise Galateau-Sallé, Christophe Blanquart, Jan P Van Meerbeeck, Thierry Berghmans, Didier Jean, Pierre P Roger
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition. Molecular oncology (2022)
Laurent Mathiot, Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart, Marc Guillaume Denis, Elvire Pons-Tostivint
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature. Current oncology (Toronto, Ont.) 29 (5) (2022)
Ananya Hariharan, Weihong Qi, Hubert Rehrauer, Licun Wu, Manuel Ronner, Martin Wipplinger, Jelena Kresoja-Rakic, Suna Sun, Lucia Oton-Gonzalez, Marika Sculco, Véronique Serre-Beinier, Clément Meiller, Christophe Blanquart, Jean-François Fonteneau, Bart Vrugt, Jan Hendrik Rüschoff, Isabelle Opitz, Didier Jean, Marc de Perrot, Emanuela Felley-Bosco
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment. Molecular oncology 16 (22) (2022)
Hoa-Le Mai, Sophie Deshayes, Thi-Van-Ha Nguyen, Virginie Dehame, Anne-Laure Chéné, Sophie Brouard, Christophe Blanquart
IL-7 is expressed in malignant mesothelioma and has a prognostic value. Molecular oncology 16 (20) (2022)
Thibaut Blondy, Julien Poly, Camille Linot, Joanna Boucard, Emilie Allard-Vannier, Steven Nedellec, Phillipe Hulin, Céline Hénoumont, Lionel Larbanoix, Robert N Muller, Laurent Sophie, Etienne Bequet-Ermoy, Christophe Blanquart
Impact of RAFT chain transfer agents on the polymeric shell density of magneto-fluorescent nanoparticles and their cellular uptake. Nanoscale 14 (15) (2022)
Thibaut Blondy, Sènan Mickael d'Almeida, Tina Briolay, Julie Tabiasco, Clément Meiller, Anne-Laure Chéné, Laurent Cellerin, Sophie Deshayes, Yves Delneste, Jean-François Fonteneau, Nicolas Boisgerault, Jaafar Bennouna, Marc Grégoire, Didier Jean, Christophe Blanquart
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma. Journal for immunotherapy of cancer 8 (1) (2021)
Lyna Kara-Terki, Lucas Treps, Christophe Blanquart, Delphine Fradin
Critical Roles of Tumor Extracellular Vesicles in the Microenvironment of Thoracic Cancers. International journal of molecular sciences 21 (17) (2020)
Pierre Autin, Christophe Blanquart, Delphine Fradin
Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors. Cancers 11 (10) (2019)
Patrick Smeele, Sènan Mickaël d'Almeida, Clément Meiller, Anne-Laure Chéné, Charly Liddell, Laurent Cellerin, François Montagne, Sophie Deshayes, Sarah Benziane, Marie-Christine Copin, Paul Hofman, Françoise Le Pimpec-Barthes, Henri Porte, Arnaud Scherpereel, Marc Grégoire, Didier Jean, Christophe Blanquart
Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis. Molecular cancer 17 (1) (2018)
Douae Bensaid, Thibaut Blondy, Sophie Deshayes, Virginie Dehame, Philippe Bertrand, Marc Grégoire, Mohammed Errami, Christophe Blanquart
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma. Clinical epigenetics 10 (2018)

Christophe Blanquart.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christophe Blanquart